Zumutor Biologics is a biotech company working on cancer therapies and currently advancing clinical trials for its programs. The company announced it raised $7.3 million, which the report states will be used to progress those clinical studies. The article does not include details on commercial products, revenues, users, or other operating metrics. It also does not provide information on the company's founding year, location, or past financing rounds. The available coverage is focused on the new capital and its intended application toward clinical development.

Total raised

$18M

Funding rounds

3

Latest round

Series B

Latest activity

Jun 2026